FTC wins $448 million disgorgement from AbbVie and Besins

Pallavi Guniganti

02 July 2018

AbbVie has said it will appeal its loss against the Federal Trade Commission in a lawsuit for monopolising Androgel through sham litigation, as a Pennsylvania federal court ordered the drugmaker and Besins Healthcare to pay $448 million to consumers.

Subscribe to Global Competition Review

Subscribe to unlock unlimited access

Get news, unique commentary, expert analysis and essential resources from the Global Competition Review experts.

Subscribe now

Already have access? Login below

Pallavi Guniganti

View full biography

Author

[email protected]

Unlock unlimited access to all Global Competition Review content